⌘K

Login Start Free

Home/Filings/4/0000950170-24-139063

4//SEC Filing

Nabulsi Azmi 4

Accession 0000950170-24-139063

CIK 0001783183other

View on SEC.gov Company Profile

Filed

Dec 19, 7:00 PM ET

Accepted

Dec 20, 4:21 PM ET

Size

6.1 KB

Accession

0000950170-24-139063

Insider Transaction Report

Form 4

Period: 2024-12-19

Phathom Pharmaceuticals, Inc.PHAT

Chief Operating Officer

Transactions

Sale
Common Stock
2024-12-19$8.00/sh−1,118$8,944→ 239,303 total

Holdings

Common Stock
(indirect: By 401(k))
3,578.93
Common Stock
(indirect: By Trust)
785,700

Footnotes (1)

[F1]Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Phathom Pharmaceuticals, Inc.

CIK 0001783183

Entity typeother

Related Parties

1

filerCIK 0001791412

Filing Metadata

Form type: 4
Filed: Dec 19, 7:00 PM ET
Accepted: Dec 20, 4:21 PM ET
Size: 6.1 KB

View on SEC.gov